Cxcl13-KO 基因敲除小鼠

1. Ukita, Masayo, Hamanishi, Junzo, Yoshitomi, Hiroyuki, Ueno, Hideki, Mandai, Masaki. 2022. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer. In JCI insight, 7, . doi:10.1172/jci.insight.157215. https://pubmed.ncbi.nlm.nih.gov/35552285/

2. Law, Calvin, Wacleche, Vanessa Sue, Cao, Ye, Choi, Jaehyuk, Rao, Deepak A. 2024. Interferon subverts an AHR-JUN axis to promote CXCL13+ T cells in lupus. In Nature, 631, 857-866. doi:10.1038/s41586-024-07627-2. https://pubmed.ncbi.nlm.nih.gov/38987586/

3. Cabrita, Rita, Lauss, Martin, Sanna, Adriana, Svane, Inge Marie, Jönsson, Göran. 2020. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. In Nature, 577, 561-565. doi:10.1038/s41586-019-1914-8. https://pubmed.ncbi.nlm.nih.gov/31942071/

4. Wang, Jie, Yin, Chengyu, Pan, Yushuang, Fang, Jianqiao, Liu, Boyi. 2023. CXCL13 contributes to chronic pain of a mouse model of CRPS-I via CXCR5-mediated NF-κB activation and pro-inflammatory cytokine production in spinal cord dorsal horn. In Journal of neuroinflammation, 20, 109. doi:10.1186/s12974-023-02778-x. https://pubmed.ncbi.nlm.nih.gov/37158939/